调节肠道微生物组以改善2型糖尿病的全球研究趋势:图书计量和视觉分析
Rongsheng Jiang1, Zhengri Cong1, Likun Zheng1
1College of Acupuncture and Tuina, Changchun University of Chinese Medicine, Changchun, China.
Frontiers in endocrinology
|June 18, 2024
概括
对肠道微生物组 (GM) 和2型糖尿病 (T2DM) 的研究表明,GM的调制可以改善T2DM. 未来的研究将重点关注T2DM并发症,转基因调控方法和新的实验技术.
科学领域:
- 微生物学 微生物学
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
背景情况:
- 肠道微生物组 (GM) 和2型糖尿病 (T2DM) 呈现出双向关系.
- 通过饮食,运动和药物调节转基因是对T2DM管理的日益增长的研究领域.
- 这一研究领域缺乏全面的文献计量分析.
研究的目的:
- 系统地分析知识结构,研究热点和GM和T2DM领域的趋势.
- 提供有关转基因和T2DM的科学成果的文献统计概述.
- 确定该领域的关键贡献者和有影响力的出版物.
主要方法:
- 从Web of Science核心收藏中对2008年至2023年间发表的1004篇文章进行了图书统计分析.
- 使用微软Excel发布趋势,使用CiteSpace分析机构,期刊,参考文献和关键词.
- 雇佣的SCImago Graphica用于国家/地区,协作,作者和期刊分析.
主要成果:
- 出版物输出显示了上升趋势,在2022年达到顶峰.
- 中国在出版物方面处于领先地位;哥本哈根大学是领先的机构.
- 关键词包括肠道微生物群,肥胖和胰岛素抵抗,研究重点是饮食,运动和药理干预措施.
结论:
- 目前的研究证实了转基因调节的有效性和改善T2DM的机制.
- 未来的研究应该调查转基因对T2DM并发症和生理过程的影响.
- 开发特定的转基因监管方法和新型实验技术至关重要.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Carbohydrate Metabolism
11.0K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.0K
Diabetes: Management and Pharmacotherapy
257
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
257
Glucagon-like Receptor Agonists
316
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
316
Pathophysiology of Diabetes
919
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
919


